Surgical Morbidity in Retroperitoneal Sarcoma Resection
Overview
Oncology
Authors
Affiliations
Resection of retroperitoneal sarcoma (RPS) typically involves multivisceral resection. The morbidity of RPS resection has decreased over time despite widespread adoption of radical resection. Certain patterns of resection are associated with higher complication rates and elderly patients are at increased risk of morbidity. Administration of preoperative radiotherapy does not increase morbidity, but intraoperative and brachytherapy techniques are associated with heightened toxicities. Long-term functional outcomes and quality of life scores after RPS resection are acceptable.
Kamarajah S, Baia M, Naumann D, Mahmood F, Parente A, Almond M BJS Open. 2023; 7(4).
PMID: 37498965 PMC: 10373904. DOI: 10.1093/bjsopen/zrad059.
Retroperitoneal sarcomas: Outcomes of repeated resections.
Hwang H, Kwon Y, Lim H, Kim J, Park K Korean J Clin Oncol. 2023; 16(2):96-103.
PMID: 36945717 PMC: 9942735. DOI: 10.14216/kjco.20015.
Retroperitoneal Sarcomas: a Current Review on Management.
Patkar S, Kattepur A, Khanna N, Bajpai J Indian J Surg Oncol. 2022; 13(3):542-558.
PMID: 36187536 PMC: 9515254. DOI: 10.1007/s13193-022-01520-y.
Munoz P, Bretcha-Boix P, Artigas V, Asencio J Cancers (Basel). 2022; 14(17).
PMID: 36077627 PMC: 9454716. DOI: 10.3390/cancers14174091.
Flacs M, Faron M, Mir O, Mihoubi F, Sourouille I, Haddag-Miliani L J Gastrointest Surg. 2020; 25(9):2299-2306.
PMID: 33236323 DOI: 10.1007/s11605-020-04882-2.